Device Updates from Abbott, Dexcom, Insulet, Medtronic, and Tandem

“Adam, what do you eat when you’re on a plane?” My six go-to strategies from hundreds of flights and airports

Studies highlight reduced hypoglycemia risk for people with type 2 diabetes who switch to “next-gen” basal insulins Toujeo or Tresiba

Dexcom CGM for Medicare shipments start with hopefully more to come, Ascencia Contour Next One meter added, and why remote monitoring is not enabled

Lilly announces new program, in partnership with Express Scripts, to provide insulin directly to people with diabetes and high out of pocket drug expenses

Information about diabetes supplies for those hit by the storms and for those who can help them

How do I stay in range while sleeping?

Research presented at ADA’s 2017 conference shows exciting advances in a host of diabetes drugs – including heart benefits, improved glucose control, lower cholesterol,...

Winning ideas aim to improve insulin safety, monitor for foot ulcers, and incorporate user insight into product development

FDA approves Lucentis for all types of diabetic retinopathy and IBM announces a new technology that helps doctors better diagnose retinopathy

A new basal insulin is on the horizon in the US with Merck’s LUSDUNA Nexvue, but launch timing obscured by ongoing lawsuit

The FDA decision on Novo Nordisk’s basal insulin is based on positive safety and efficacy data of Tresiba versus other basal insulins

Jim Hirsch, diaTribe contributor and bestselling author, weighs in on a damaging diabetes myth

Best-selling author on why he believes “calories in-out” is not an explanation for obesity, why we need better science, and nutrition recommendations for people with...

Results from the type 2 diabetes group in Dexcom’s DIaMonD trial show A1c and time-in-range benefits

A major call for creativity, urgency, and new approaches to behavior change from expert panelists at SXSW 2017

Kelly Close and Adam Brown lead expert panel discussion at The diaTribe Foundation’s second annual diabetes digital health gathering at ADA 2017

The U.S. Food and Drug Administration (FDA) has approved the once-weekly injectable Ozempic (semaglutide) for use in type 2 diabetes.

Healthcare professionals are increasingly recognizing peer support as a valuable element of diabetes care; read for a list of peer support communities

App allows FreeStyle Libre sensor users to monitor blood sugar on their smartphone without a separate reader. Tools also available for sharing glucose data with...